Dr. Reddy’s will make a $7.5 million upfront payment to Coya. Under the terms of the agreement, Coya has granted Dr Reddy’s an exclusive license to commercialise COYA 302
India Business News: NOIDA: India's pharmaceutical business may exceed $130 billion by 2030, supported by expanding market opportunities and heightened demand in the overs.
Chairman of PharmExcil (Pharmaceuticals Export Promotion Council of India) Veeramani S V said the Indian pharmaceutical industry is on a compelling growth trajectory, evidenced by an 8 per cent year-to-date increase in exports and a remarkable 29 per cent surge in October alone.
The market was trading flat at noon on mixed Asian cues with IT stocks under selling pressure once again, About 1,688 shares advanced, 1,391 declined, and 105 were unchanged.